Your session is about to expire
← Back to Search
Behavioural Intervention
Intervention for Mild Cognitive Impairment
N/A
Waitlist Available
Led By John D Piette, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (up to approximately 1 hour and 15 minutes over the course of two meetings).
Awards & highlights
Study Summary
This study is evaluating whether a new approach to teaching English to individuals who are learning the language may be effective.
Eligible Conditions
- Mild Cognitive Impairment
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (up to approximately 1 hour and 15 minutes over the course of two meetings).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (up to approximately 1 hour and 15 minutes over the course of two meetings).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of MCI/SCD (Mild Cognitive Impairment/Subjective Cognitive Decline) Participants Recruited Within the First Six Months
Other outcome measures
Geriatric Depression Scale
Psychological Wellbeing Scale (PWB)
UCLA Revised Loneliness Scale
Trial Design
2Treatment groups
Experimental Treatment
Group I: Wait-list ControlExperimental Treatment1 Intervention
Participants will wait 8 weeks and then they will be paired with an English language learner and engage in 8 weeks, 1 hour videoconferencing sessions.
Group II: InterventionExperimental Treatment1 Intervention
Participants will be paired with an English language learner and engage in 8 weeks, 1 hour videoconferencing sessions.
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,058 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,805 Total Patients Enrolled
John D Piette, PhDPrincipal InvestigatorUniversity of Michigan
8 Previous Clinical Trials
2,984 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger